We describe a male patient who developed systemic sclerosis following orchiectomy, radiotherapy and anti-androgenic treatment for prostatic adenocarcinoma. This case appears interesting as it further supports the possibility of a relationship between neoplasia and systemic sclerosis. The concurrence of scleroderma and iatrogenic hypoandrogenism suggests that hormonal influences may also play a role in the pathogenesis of this connective tissue disorder.
Giordano, N.G., Magaro, L., Fattorini, L., Marcucci, P., Fioravanti, A., Marcolongo, F.R. (1993). Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma. CLINICAL RHEUMATOLOGY, 12(1), 81-84 [10.1007/BF02231564].
Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma
Giordano, N. G.;Fattorini, L.;Marcucci, P.;Fioravanti, A.;Marcolongo, F. R.
1993-01-01
Abstract
We describe a male patient who developed systemic sclerosis following orchiectomy, radiotherapy and anti-androgenic treatment for prostatic adenocarcinoma. This case appears interesting as it further supports the possibility of a relationship between neoplasia and systemic sclerosis. The concurrence of scleroderma and iatrogenic hypoandrogenism suggests that hormonal influences may also play a role in the pathogenesis of this connective tissue disorder.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/42561
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo